New York, United States , June 24, 2024 (GLOBE NEWSWIRE) -- The Global Tissue Diagnostics Market Size is to Grow from USD 4.9 Billion in 2023 to USD 10.8 Billion by 2033, at a Compound Annual Growth Rate (CAGR) of 8.22% during the projected period.
Get a Sample PDF Brochure: https://www.sphericalinsights.com/request-sample/4590
In tissue diagnostics, small fragments of tissue from the body are analyzed to find disorders like cancer. During biopsies or procedures, physicians collect tissue samples. These samples are then inspected under a microscope to look for any unusual cells or structures. Tissue diagnostics is a vital tool for the identification, monitoring, and management of diverse cancer cases. To detect disease signs and symptoms, biopsies include taking a sample from an area of interest, such as skin, tissue, or a tumor. It is used in the assessment and diagnosis of several ailments, including cancer, autoimmune disorders, infectious diseases, and genetic disorders. The wide use of digital pathology systems by medical professionals is a result of the ongoing trend of automation in diagnostic laboratory operations in the major healthcare markets. In addition, improved laboratory productivity is necessary for patients and medical professionals to promptly and accurately diagnose illnesses and create effective treatment regimens. Using digital and automated techniques more frequently allows laboratory personnel to diagnose diseases in a more rapid and economical manner. However, The FDA's current approval procedure for tissue diagnostic tools and supplies is a serious obstacle for businesses looking to introduce innovative products. Since many of these are categorized as Class III, which is the strictest application procedure that looks at safety and efficacy, they require extensive Premarket Approval (PMA).
Browse key industry insights spread across 230 pages with 110 Market data tables and figures & charts from the report on the "Global Tissue Diagnostics Market Size, Share, Growth Analysis, By Product (Consumables, and Instrument), By Technology (Immunohistochemistry (IHC), In Situ Hybridization (ISH), Digital Pathology & Workflow, and Special Staining), By Application (Breast Cancer, Prostate Cancer Gastric Cancer, and Other), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033."
Buy Now Full Report https://www.sphericalinsights.com/checkout/4590
The consumables segment is anticipated to hold the greatest share of the global tissue diagnostics market during the projected timeframe.
On the basis of product, the global tissue diagnostics market is divided into consumables, and instrument. Among these, the consumables segment is anticipated to hold the greatest share of the global tissue diagnostics market during the projected timeframe. It is anticipated that market would expand as a consequence of rising R&D expenditures by leading pharmaceutical companies and rising governmental and private sector financing for cancer and life sciences research.
The immunohistochemistry (IHC) segment is anticipated to grow at the fastest pace in the global tissue diagnostics market during the projected timeframe.
On the basis of technology, the global tissue diagnostics market is divided into immunohistochemistry (IHC), in situ hybridization (ISH), digital pathology & workflow, and special staining. Among these, the immunohistochemistry (IHC) segment is anticipated to grow at the fastest pace in the global tissue diagnostics market during the projected timeframe. IHC tests particular antigens in tissue using antibodies by combining immunological, anatomical, and biochemical methods. Antibodies that exhibit a high level of specificity are employed in the binding and detection of antigens.
The breast cancer segment is predicted to grow at the highest pace in the tissue diagnostics market during the estimated period.
On the basis of application, the global tissue diagnostics market is divided into breast cancer, prostate cancer, gastric cancer, and other. Among these, the breast cancer segment is predicted to grow at the highest pace in the tissue diagnostics market during the estimated period. Breast cancer is a serious worldwide health concern that requires accurate tissue diagnostics for early detection, diagnosis, and therapy planning. More and more studies of breast tissue samples are using sophisticated techniques like in situ hybridization and immunohistochemistry to accurately define tumors.
Inquire Before Buying This Research Report: https://www.sphericalinsights.com/inquiry-before-buying/4590
North America is expected to hold the largest share of the global tissue diagnostics market over the forecast period.
North America is expected to hold the largest share of the global tissue diagnostics market over the forecast period. The region's need for cancer diagnosis is rising and there are numerous government initiatives aimed at this end. The cancer prevention and control research institute are a historic effort of the canters for disease control and prevention, devoted to the study of cancer prevention in that area. The US precision medicine initiative is contributing to the growth of the personalized medicine market in North America.
Asia Pacific is predicted to grow at the fastest pace in the global tissue diagnostics market during the projected timeframe. In light of increased utilization of certain tissue diagnostic tests provided by overseas companies, the region of Asia-Pacific is expected to expand profitably over the projected period. Asia Pacific has seen an increase in the public's awareness of health-related issues and an introduction to the newest available technologies.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the global market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market. Major vendors in the global tissue diagnostics market include F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific Inc., Siemens, Danaher, bioMérieux SA, QIAGEN, Merck KGaA, GE Healthcare, BioGenex, Cell Signaling Technology, Inc.,Bio SB, DiaGenic ASA, Agilent Technologies, and others.
Get Discount At @ https://www.sphericalinsights.com/request-discount/4590
Recent Developments
- In January 2023, Agilent Technologies, Inc. has entered into a partnership with Akoya Biosciences, Inc. to develop multiplex-immunohistochemistry diagnostic solutions. This collaboration intends to commercialize workflow solutions for multiplex assays dedicated to tissue analysis, ultimately providing a comprehensive multiplex IHC solution for biomarker clinical research, facilitated by digital pathology.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global tissue diagnostics market based on the below-mentioned segments:
Global Tissue Diagnostics Market, By Product
- Consumables
- Instrument
Global Tissue Diagnostics Market, By Technology
- Immunohistochemistry (IHC)
- In Situ Hybridization (ISH)
- Digital Pathology & Workflow
- Special Staining
Global Tissue Diagnostics Market, By Application
- Breast Cancer
- Prostate Cancer
- Gastric Cancer
- Other
Global Tissue Diagnostics Market, Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
Browse Related Reports
Global Nucleotides Market Size, Share, and COVID-19 Impact Analysis, By Nitrogenous Base (Purine and Pyrimidine), By Application (Diagnostics Research, Pharmaceuticals, and Others), By Technology (TaqMan Allelic Discrimination and SNP By Pyrosequencing), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033
Global Skin Rash Treatment Market Size, Share, and COVID-19 Impact Analysis, By Skin Rash Type (Contact Dermatitis, Eczema, Psoriasis, Hives, Viral, and Others), By Treatment Type (Corticosteroids, Immunosuppressants, Antihistamines, Antifungals, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033.
Global Nasal Spray Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Corticosteroids, salt water solutions, Topical Decongestants, Antihistamine, and Others), By Application (Nasal Allergies, Cold Asthma, and Others), By Age Group (Pediatric and Adults), By Distribution Channel (Drug Stores & Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033
Global Insulin Glargine Market Size, Share, and COVID-19 Impact Analysis, By Type (Lantus, Basaglar, Toujeo, Soliqua, Rezvoglar, and Others), By Diabetes Type (Type 2 Diabetes, Type 1 Diabetes), By Distribution Channel (Hospital Pharmacies, Online Pharmacies and Retail Pharmacies), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Follow Us: LinkedIn | Facebook | Twitter
